Skip to main content
. 2016 Mar 10;8(3):78. doi: 10.3390/v8030078

Figure 6.

Figure 6

Figure 6

Antigen capsid-incorporation vector elicits an in vivo T. cruzi humoral immune response. (A) Study design: C57BL/6 mice (n = 7) were primed and boosted with 3 × 1010 VP of Ad5, Ad5-pIX-gp83, Ad5-pIX-ASP-C, Ad48, Ad48-pIX-gp83, or Ad48-pIX-gp83. Two weeks after the last immunization serum was collected for ELISA binding assays. Either 10 μM of gp83 peptide or the ASP-C peptide was bound to ELISA plates; (B) Post-prime and post-boost serum from mice immunized with the T. cruzi gp83 modified vectors; (C) Post-prime and post-boost serum from mice immunized with the T. cruzi ASP-C pIX-modified vectors. The amount of anti-gp83 and anti-ASP-C antibodies in the sera was expressed as the mean ± SEM. (*) = p ≤ 0.05.